/

Bruker Corporation

BRKR US

BRKR USBruker Corporation

United States Composite

82.20

USD

-0.26

(-0.32%)

2.90EPS Dil.

28.17P/E

11.93BMarket Cap

0.24%Div. Yield

Next Earnings

May 2

Ex-Dividend Date

February 29

Dividend Date

March 15

Held by Insiders

34.66%

Held by Institutions

80.99%

Short % of Float

3.18%

YTD Yield

18.27%

3Y Yield

30.92%

5Y Yield

141.00%

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

121

145

LT Borrowings

1,123

1,099

1,160

LT Finance Leases

- -

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

147

146

145

Market Capitalization

10,853

9,090

10,667

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

2,183

2,029

2,164

Cash, Cash Equivalents & STI

575

364

488

Accounts Receivable, Net

451

485

492

Inventories

915

916

968

Total Current Liabilities

1,051

1,072

1,202

Payables & Accruals

189

182

456

ST Debt

121

145

Deferred Revenue

397

381

400

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

5.30%

9.74%

17.15%

Net Income, GAAP

29.63%

23.19%

43.77%

Free Cash Flow

23.03%

13.18%

67.59%

Total Cash Common Dividend

- -

3.53%

-3.33%

Total Equity

5.81%

9.09%

24.82%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

555

571

609

684

2,418

2022

595

588

639

708

2,531

2023

685

682

743

855

2,965

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

0.37

0.38

0.58

0.50

1.83

2022

0.41

0.33

0.60

0.66

2.00

2023

0.52

0.39

0.60

1.41

2.92

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

0.04

0.16

2022

0.05

0.20

2023

0.05

0.20

Company Description

CEO: Dr. Frank H. Laukien Ph.D., Dr. Burkhard Prause Ph.D.
Full Time Employees: 9,707
Sector: Healthcare
Industry: Medical Devices
Address: 40 Manning Road Billerica MA United States 01821
IPO Date: Aug 4, 2000
CIK: 0001109354
Website: www.bruker.com
Business: Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Company News

Yahoo
24 days ago
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
Zacks
a month ago
Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?
Tipranks
a month ago
Analysts Offer Insights on Healthcare Companies: Bruker (BRKR), Inspire Medical Systems (INSP) and Pfizer (PFE)
Yahoo
a month ago
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
Zacks
a month ago
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
Zacks
a month ago
Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?
Zacks
a month ago
Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO
Yahoo
a month ago
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
Yahoo
2 months ago
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
Yahoo
2 months ago
Director Hermann Requardt Sells 15,000 Shares of Bruker Corp (BRKR)
Zacks
2 months ago
Here's Why Investors Should Retain Bruker (BRKR) Stock Now
Yahoo
2 months ago
Here's Why Investors Should Retain Bruker (BRKR) Stock Now

Company Description

CEO: Dr. Frank H. Laukien Ph.D., Dr. Burkhard Prause Ph.D.
Full Time Employees: 9,707
Sector: Healthcare
Industry: Medical Devices
Address: 40 Manning Road Billerica MA United States 01821
IPO Date: Aug 4, 2000
CIK: 0001109354
Website: www.bruker.com
Business: Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Company News

Yahoo
24 days ago
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
Zacks
a month ago
Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?
Tipranks
a month ago
Analysts Offer Insights on Healthcare Companies: Bruker (BRKR), Inspire Medical Systems (INSP) and Pfizer (PFE)
Yahoo
a month ago
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
Zacks
a month ago
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
Zacks
a month ago
Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?
Zacks
a month ago
Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO
Yahoo
a month ago
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
Yahoo
2 months ago
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
Yahoo
2 months ago
Director Hermann Requardt Sells 15,000 Shares of Bruker Corp (BRKR)
Zacks
2 months ago
Here's Why Investors Should Retain Bruker (BRKR) Stock Now
Yahoo
2 months ago
Here's Why Investors Should Retain Bruker (BRKR) Stock Now